Document:

Exhibit 10.18

 

Consulting
Agreement

 

This
consulting agreement (the “Agreement”) is made and entered on this day 1st day of July, 2019 (the “Effective
Date”) by and between PYP Enterprises (hereinafter referred to as the “Consultant”) and Electromedical Technologies,
Inc. (hereinafter referred to as the “Client”).

 

	1.	Services

 

The
Consultant will provide strategic business services to the Client, which may include: Assisting with the Compensation Plan, Consulting
on MLM program, Website design and SEO consulting.

 

 

	2.	Compensation and Reimbursement
                                         of Expenses

 

The
Client agrees to pay the Consultant a fixed fee of ten thousand (10,000) r e st r ic t e d common shares for the services provided.
This fee shall cover services pursuant to Section 1 of this Agreement. The total amount owed per this agreement shall be deemed
earned in full on September 30, 2019. For purposes of this agreement, the shares are va1ued at $0.71 per share.

 

The
Consultant will maintain adequate documentation and records to support all costs invoiced to the Client including receipts for
travel related expenses however, such expenses must be approved by the Client prior to being incurred by Consultant.

 

Payments
made by the Client to the Consultant will not deduct any taxes and the Client will provide the Consultant with IRS Form 1099 at
the end of each calendar year. For purposes of issuing IRS Form 1099, the Consultant will provide a social security number upon
execution of his agreement.

 

The
shares of Common Stock provided for a compensation to Consultant may not be sold or transferred unless:

 

(i)
such shares are sold pursuant to an effective registration statement under the Act or (ii) the Consultant or its transfer agent
shall have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions
of counsel in comparable transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant
to an exemption from such registration (iii) such shares are sold or transferred pursuant to Rule 144 under the Act (or a successor
rule) (“Rule 144”).

 

The
certificate for shares of Common Stock has not been so included in an effective registration statement or that has not been sold
pursuant to an effective registration statement or an exemption that permits removal of the legend, shall bear a legend substantially
in the following form, as appropriate:

 

     

     

    

 

“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HA VE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN
A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

 

	3.	Term and Termination

 

This
agreement will commence on the effective date set forth and continue for a period of t h r e e months from the effective date
unless terminated earlier. Either party may terminate this agreement at any time upon thirty-day (30) notification. The Client
may at its option agree to renew, extend and revise this agreement prior to its expiration.

 

	4.	Confidential Information

 

Both
parties acknowledge that there is an exchange of confidential and proprietary information associated with this agreement. Confidential
and proprietary information may include documents, communications, plans, processes, formulations, data, know-how, financial information,
techniques, methods, customers, suppliers, partners, patents, trademarks, designs, and other forms of tangible or intangible artifacts
owned by the Client. Confidential and proprietary information does not include information within the public domain, information
that has been publicly known prior to the execution of this agreement, or information that the Consultant developed independent
of any confidential information.

 

The
Consultant will not divulge, disseminate, publish or otherwise disclose any information without the prior consent of the Client.
The Consultant will not use any information for purposes other than the performance of services described in this agreement. The
Client agrees to not disclose confidential information to the Consultant except to the extent that the Consultant requires this
information to fulfill the obligations within this agreement.

 

If
the Client has any concerns over the sharing of sensitive information and requires additional control measures, the Consultant
will establish secured means of information sharing that are mutually agreeable to both parties. These control measures may include
restricting who can copy, print, or change documents during the course of the engagement.

 

     

     

    

 

	5.	Indemnification

 

Notwithstanding
other provisions of this agreement, the Client shall indemnify, defend and hold harmless the Consultant against claims, liabilities,
damages, losses or other obligations, which may arise from this agreement.

 

	6.	Relationship of Parties

 

The
parties agree that this agreement creates an independent contractor relationship, not an employment relationship. Neither party
is, nor shall claim to be, a legal agent, representative, partner, or employee of the other, and neither shall have the right
or authority to contract in the name of the other, nor shall it assume or create any obligations, debts, accounts or liabilities
for the other.

 

	7.	Role of the Consultant

 

The
Consultant will not make management decisions on behalf of the Client. The role of the Consultant shall be advisory in nature
with no perceived conflicts of interest prior to, during or after the engagement with the Client. This role will also extend to
any third parties that the Consultant may use during the course of the engagement.

 

	8.	Reliance on Client Provide
                                         Information

 

Regarding
any information or material that the Company furnishes to Consultant or any other entity in connection with this Agreement, the
Company acknowledges and confirms that (i) Consultant will use and rely on such information and material without independently
verifying the same, (ii) Consultant does not assume responsibility for the accuracy or completeness of any of the information
or material, (iii) Consultant will not make any appraisal, evaluation or independent determination regarding such information
or material or the Company and (iv) Consultants shall not have any liability in connection with such information or material.
The Company represents to Consultant that the information and material to be furnished by the Company, when delivered, will be
true, complete and correct in all material respects and will not contain any material misstatement of fact or omit to state any
material fact necessary to make the statements contained therein not misleading. The Company shall promptly notify Consultants
if it learns of any material inaccuracy or misstatement in, or material omission from, any information or material delivered to
Consultant.

 

	9.	Quality Assurance and
                                         Control

 

In
an effort to ensure that the Consultant provides high quality work, the Client will assign the CEO of the Client company to review
and approve the work of the Consultant. In the event that the Consultant uses a third party, the Consultant is responsible for
the quality of the work delivered by the third party.

 

     

     

    

 

	10.	Non-Agent of Client

 

It
is understood that Consultant is not acting as agent or fiduciary of, and have no liabilities to, the equity holders of the Company
or any other third party in connection with this Agreement or any introductions, services or transactions hereunder, all of which
liabilities are expressly waived.

 

	11.	Clawback

 

The
compensation granted under this agreement are subject to the terms of the client’s recoupment, clawback or similar policy
as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances
(e.g. failure to perform throughout the term, gross negligence, violation of State laws, violation of SEC regulations) require
repayment or forfeiture of compensation or any shares of Common Stock or other cash or property received.

 

	12.	Governing Law

 

This
Agreement shall be governed by and interpreted in accordance with the laws of the state of A r i z o n a applicable to agreements
negotiated, executed and to be performed in the state, without regard to the choice or conflicts of law rules or principles of
that state. The parties hereto hereby consent to the jurisdiction of the state courts located in Scottdale, Arizona, over the
parties and any disputes, claims, actions, suits and proceeding relating to this agreement or the transactions contemplated herein.

 

	13.	NOTICES. All
                                         notices to be furnished pursuant to this Agreement shall be by email as follows:

 

If
to the Client: Matthew Wolfson

Email: CEO@electromed.com

 

With
a copy to:

 

Eric P. Littman, Esquire

Email: littmanlaw@gmail.com

 

If
to Consultant:

 

PYP
Enterprises

Email:
cgmusc@gmail.comExhibit 10.19

 

STOCK PURCHASE AGREEMENT

 

This Stock Purchase Agreement is dated as of this 25th day of
March, 2019 by and between Matthew Wolfson (the “Seller”) and Nicholas Rosin (the “Buyer’).

 

WHEREAS, the Buyer is an employee of Electromedical Technologies,
Inc., a Delaware company (the “Company’”); and

 

WHEREAS, Previously, the Seller has orally agreed to sell 25,000
shares of his shares of the Company (the “Shares”) to the Buyer for the par price per share Seller paid for his shares
of the Company; and

 

WHEREAS, the Seller and Buyer agree that it is in their best
interest to memorialize in writing the sale of the Shares.

 

NOW THEREFORE, in consideration of the mutual promises, covenants,
representations and warranties contained herein, and other good and valuable consideration, and with the intent that, upon consummation
of the transactions contemplated herein, and upon the terms set forth herein the parties hereby agree to as follows:

 

	1.	The Seller agrees to sell, and Buyer agrees to purchase, the Shares for $2.50.

 

	2.	Seller represents that he has good and marketable title to the Shares.

 

	3.	The Shares will bear a restricted legend unless registered by the Company is a S-1 Registration Statement.

 

	4.	The Company will use its best efforts to register the Shares on Form S-1 or such other form that is legally permissible.

 

IN WITNESS WHEREOF., the parties have executed this Agreement
as of the date first written above.

 

SELLER: MATTHEW WOLFSON BUYER: NICHOLAS ROSIN

 

Weekes

 

Matinew/ffotison Nicholas Rosir’ a

 

ELECTROMEDICAL TECHNOLOGIES, INC. AWARD AGREEMENT - 2017 EMPLOYEE
AND CONSULTANT STOCK OWNERSHIP PLAN - OPTIONS

 

Participant Name: Nicholas Rosin Participant ID: N/A

 

Type of Option: Nonstatutory Stock Option Grant Date: March
10, 2019

 

Exercise Price: $0.71

 

Shares Granted: 75,000

 

    

     

    

 

Term and Vesting Date(s): Only if the participant is still a
consultant or employee of Electromedical Technologies, Inc. as follows: (1) 25,000 shares on January 1, 2020; (2) 25,000 shares
on January 1, 2021; and (3) 25,000 shares on January 1, 2022. If the participant is not an employee or consultant of Electromedical
Technologies on the Vesting Date, the Grant shall automatically lapse and be terminated.

 

Expiration Date: June 30, 2022 Acceptance Date: March 11, 2019

 

This Award Agreement (referred to below as this “Agreement”)
spells out the terms and conditions of the stock option (the “Option”) granted to you by ElectroMedical Technologies,
Inc., a Delaware corporation (the “Company”), pursuant to the 2017 Employee and Consultant Stock Option Plan (the “Plan”)
on and as of the Grant Date designated above. Except as otherwise defined herein, capitalized terms used in this Agreement have
the respective meanings set forth in the Plan. The Plan, as in effect on the date of this Agreement and as it may be amended from
time to time, is incorporated into this Agreement by this reference.

 

You and the Company agree as follows:

 

	1.	Grant of Stock Option.

 

Pursuant to the approval and direction of the Administrator,
the Company hereby grants you an Option to purchase all or any part of the number of Shares Granted set forth above of common stock
of the Company, par value $0.00001 (“Common Stock”), at the per-share Exercise Price set forth above, which is 100%
of the Fair Market Value of a share of Common Stock on the Grant Date, subject to the terms and conditions of the Plan and this
Agreement. For the avoidance of doubt, only Incentive Stock Options, and not Nonstatutory Stock Options, will be treated as incentive
stock

 

Page 1 of 6 options within the meaning of Code Section 422 and
the Treasury Regulations promulgated thereunder. If you are not a resident or citizen of the United States, the Company is not
liable to you for any loss, damage or liability you may incur in your country of residence by participating in the Plan and receiving
this Award.

 

	2.	Vesting/Exercise/Expiration.

 

The Employee or Consultant may not exercise the Option prior
to each Vesting Date set forth above absent action by the Administrator to waive or alter such restrictions or as may be permitted
under paragraphs 3, 4 or 5 below. Thereafter, except as hereinafter provided, the Employee or Consultant may exercise the Option,
to the extent it is vested, at any time and from time to time until the close of business on the Expiration Date set forth above,
subject, in the event of a Change in Control, to the Administrator’s exercise of its discretion under Section 9 of the Plan.
The Option may be exercised to purchase any number of whole shares of Common Stock, except that no purchase shall be for less
than ten (10) full shares, or the remaining unexercised shares, if less. Any Option is deemed to be “outstanding”
until it has been exercised in full or expired pursuant to the terms of this Agreement.

 

    

     

    

 

	3.	Forfeiture of Outstanding Options Following Termination of Service.

 

Without limiting Sections 3(f)(ii)-(iv) of the Plan and notwithstanding
any provision of this Agreement to the contrary, your remaining rights to any Options pursuant to this Agreement, if any, shall
immediately terminate if and when:

 

	(a)	if you are an employee receiving Incentive Stock Options, during your employment with the Company, you voluntary quit or resign,
or if you are terminated for Cause as determined by the Administrator, then your right to exercise your Incentive Stock Options
shall terminate as of the date of you cease to be employed by the Company, subject to the right of the Administrator to extend
the exercise period of this Incentive Stock Options. For purposes of this Section 3, “Cause” means any one or more
of the following, as determined by the Administrator in its sole discretion:

 

	(b)	commission of a felony or any crime of moral turpitude;

 

	(ii)	dishonesty or material violation of standards of integrity in the course of fulfilling your employment duties to the Company
or any Parent or Subsidiary;

 

	(iii)	material violation of a material written policy of the Company or any Parent or Subsidiary violation of which is grounds for
immediate termination;

 

	(iv)	willful and deliberate failure to perform your employment duties to the Company or any Parent

 

or Subsidiary in any material respect, after reasonable notice
of such failure and an opportunity to correct it; or

 

Page 2 of 6 (v) your failure to comply in any material respect
with the Foreign Corrupt Practices Act, the Securities Act, the Exchange Act, the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall
Street Reform and Consumer Protection Act of 2010, and the Truth in Negotiations Act, or any rules or regulations thereunder.

 

	(b)	if you receive either Incentive Stock Options or Nonstatutory Stock Options, you violate any obligation that you may have to
the Company during or after your employment or consultancy with the Company, including but not limited to any non-competition,
non-solicitation, confidentiality, non-disparagement or other restrictive covenant, to which you have agreed either orally or in
writing.

 

	4.	Exercise Process.

 

An Option may be exercised by giving written notice to ElectroMedical
Technologies, Inc., Attention: Plan Administrator, 16561 N g2TM4 Street, Suite 101, Scottsdale, AZ 85260 (or such other address
as the Company may specify). Alternatively, the Company may designate one or more third parties to administer the Option exercise
process and direct you accordingly. The exercise notice (a) shall be signed by you or (in the event of your death) your legal
representative, (b) shall specify the number of full shares then elected to be purchased, and (c) shall be accompanied by payment
in full of the Exercise Price of the shares to be purchased. Payment may be made in cash or by check payable to the order of the
Company, and such payment shall include any tax withholding obligation, as set forth in Section 8 below. Alternatively, the Administrator
may allow for one or more of the following methods of exercising an Option:

 

    

     

    

 

	(a)	Payment for shares as to which an Option is being exercised and/or payment of any federal, state, local or other tax withholding
obligations may be made by transfer to the Company of shares of Common Stock you already own, or any combination of such shares
and cash, having a fair market value determined at the time of exercise of the Option equal to, but not exceeding, the Exercise
Price and/or the tax withholding obligation, as the case may be.

 

	(b)	A “same day sale” transaction pursuant to which a third party (engaged by your or the Company) loans funds to you
to enable you to purchase the shares and pay any tax withholding obligations, and then sells a sufficient number of the exercised
shares on your behalf to enable you to repay the loan and any fees. The remaining shares and/or cash are then delivered by the
third party to you.

 

	(c)	A “net exercise” transaction, pursuant to which the Company delivers to you the net number of whole shares remaining
from the portion of the Option being exercised after deduction of a number of shares of Common Stock with a Fair Market Value equal
to the exercise price and a number of shares of Common Stock with a Fair Market Value equal to the amount of any tax withholding
obligations.

 

As promptly as practicable after receipt of such notice and
payment (including payment with respect to any tax withholding obligations), subject to Section 8 below, the Company shall cause
to

 

Page 3 of 6 be issued and delivered to you (or in the event
of your death to your legal representative, as the case may be), certificates for the shares of Common Stock so purchased. Alternatively,
such shares may be issued and held in book entry form.

 

	5.	Tax Withholding.

 

The Company may make such provisions and take such actions
as it may deem necessary or appropriate for the withholding of any Federal, state, local income and employment taxes and other
taxes required by law to be withheld with respect to this Agreement, including, but not limited to, deducting the amount of any
such withholding taxes from the amount to be paid hereunder, whether in Common Stock or in cash, or from any other amount then
or thereafter payable to you, or requiring you or your beneficiary or legal representative to pay to the Company the amount required
to be withheld or to execute such documents as the Administrator or its designee deems necessary or desirable to enable the Company
to satisfy its withholding obligations. The Company may refuse to deliver Common Stock if you, your beneficiary or legal representative
fail to comply with your or its obligations under this Section. Regardless of any action the Company takes with respect to any
or all income tax, social security, payroll tax, payment on account or other tax-related withholding (“Taxes”) that
you are required to bear pursuant to all applicable laws, any and all Taxes are your responsibility.

 

    

     

    

 

	6.	Limited Transferability.

 

You may not sell, transfer, pledge, assign or otherwise alienate
or hypothecate this Agreement (any rights thereunder), whether voluntarily or involuntarily or by operation of law, other than
by beneficiary designation effective upon your death, by will or by the laws of intestacy. During your lifetime this Agreement
and all rights granted hereunder shall be exercisable only by you. Notwithstanding the foregoing, you may transfer this Agreement,
in whole or in part, in accordance with Section 3(f)(iv) of the Plan and subject to any conditions specified by the Administrator
under the Plan.

 

	7.	Rights as Shareholder.

 

You shall have no rights as a shareholder of the Company with
respect to the shares of Common Stock subject to this Agreement until such time as the purchase price has been paid and a certificate
of stock for such shares has been issued to you or such shares of Common Stock have been recorded in your name in book entry form.
Except as provided in Section 9 below, no adjustment shall be made for dividends or distributions or other rights with respect
to such shares for which the record date is prior to the date on which you become the holder of record thereof. Anything herein
to the contrary notwithstanding, if a law or any regulation of the Securities and Exchange Commission or of any other body having
jurisdiction shall require the Company or you to take any action before shares of Common Stock can be delivered to you hereunder,
then the date of delivery of such shares may be delayed accordingly.

 

Page 4 of 6 8. Securities Laws.

 

Provided the Company is not subject to the reporting requirements
of Section 13 or 15(d) of the Exchange Act, you hereby represent that you are acquiring the shares of Common Stock for investment
and with no present intention of selling or transferring them and that you will not sell or otherwise transfer the shares except
in compliance with all applicable securities laws and requirements of any stock exchange on which the shares of Common Stock may
then be listed. The Company will use its best efforts to register the Option Shares on Form S-1 or such other form that is legally
permissible.

 

9, Change in Common Stock.

 

In the event of any change in Common Stock by reason of any
stock dividend, recapitalization, reorganization, split-up, merger, consolidation, exchange of shares, or of any similar change
affecting Common Stock, the number of shares of Common Stock subject to this Agreement and the Exercise Price shall be equitably
adjusted by the Administrator.

 

    

     

    

 

	10.	No Guarantee of Employment or Retainer.

 

Nothing in this Award Agreement shall interfere with or limit
in any way the right of the Company or any of its subsidiaries to terminate your employment or consultancy at any time, nor confer
upon you or any Employee or Consultant any right to continue in the employ of the Company or any of its Subsidiaries. No Employee
or Consultant shall have a right to be selected to be granted an Option or any other Award under the Plan.

 

	11.	Administrator Authority; Recoupment.

 

It is expressly understood that the Administrator is authorized
to administer, construe, and make all determinations necessary or appropriate for the administration of the Plan and this Agreement,
including the enforcement of any recoupment policy, all of which shall be binding upon you and any claimant. Any inconsistency
between this Agreement and the Plan shall be resolved in favor of the Plan.

 

	12.	Amendment or Modification, Waiver.

 

Except as set forth in the Plan, no provision of this Agreement
may be amended or waived unless the amendment or waiver is agreed to in writing, signed by you and by a duly authorized officer
of the Company. No waiver of any condition or provision of this Agreement shall be deemed a waiver of a similar or dissimilar condition
or provision at the same time, any prior time or any subsequent time.

 

Page 5 of 6 13. Governing Law and Jurisdiction. This Agreement
is governed by the substantive and procedural laws of the state of Delaware. You and the Company shall submit to the exclusive
jurisdiction of, and venue in, the courts in Arizona in any dispute relating to this Agreement.

 

	14.	Conformity with Applicable Law.

 

If any provision of this Agreement is determined to be invalid,
illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability
shall not affect the validity, legality or enforceability of any other provision of this Agreement or the validity, legality or
enforceability of such provision in any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such
jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.

 

	15.	Successors.

 

This Agreement shall be binding upon and inure to the benefit
of any successor or successors of the Company and any person or persons who shall, upon your death, acquire any rights hereunder.

 

    

     

    

 

This Agreement contains highly sensitive and confidential information.
Please handle it accordingly. Once you have read and understood this Agreement, please sign and date the document below to certify
and confirm your agreement to be bound by the terms and conditions of this Agreement and to acknowledge your receipt of the disclosure
documentation required by the Securities Act and Exchange Act (as applicable), the Plan and this Agreement and your acceptance
of the terms and conditions of the Stock Option Award granted hereunder.

 

Subject to 409A

 

ELECTROMEDICAL PARTICIPANT TECHNOLOGIES, INC.

 

By: | By: Wy eee

 

Name: samnells Wolfson Name: Nicholas Rosin

 

Title: CEO Employee/Gensuttant (strike out as applicable)

 

For and on behalf of the Administrator

 

Date: March 11, 2019 Date: March 11, 2019

 

Page 6 of 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00301-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00301-of-00352.parquet"}]]